A Study of Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma
Clinical trial NCT00486759 · TERMINATED
Trial details
- NCT number
- NCT00486759
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-26
- Primary completion
- 2011-11-30
- Enrollment
- 787
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.